Especially, the fact that complete loss of Hdac6 did not cause any overt phenotype but improved cognitive function in a disease model strongly suggests that targeting HDAC6 could be a promising strategy to treat cognitive impairment in neurodegenerative diseases such as AD. The gene discussed is HDAC6; the disease is Cognitive impairment.